» Authors » Putthapoom Lumjiaktase

Putthapoom Lumjiaktase

Explore the profile of Putthapoom Lumjiaktase including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 175
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Iemwimangsa N, Anantaya D, Oranratnachai S, Thamrongjirapat T, Lumjiaktase P, Teoh V, et al.
BMC Cancer . 2025 Feb; 25(1):333. PMID: 39994571
Background: One-year of immune checkpoint inhibitor (ICI) treatment after concurrent chemoradiation (CCRT) in unresectable stage III non-small cell lung cancer (NSCLC) is a standard of care. The precise predictive biomarkers...
2.
Lertwanichwattana T, Srivanichakorn S, Noknoy S, Ratchaseema S, Phanuphak N, Wongthavarawat K, et al.
Am J Public Health . 2025 Jan; 115(4):605-616. PMID: 39883900
To determine the overall mortality and risk factors of COVID-19 patients who were admitted to the Home Isolation (HI) program in Bangkok, Thailand, during the epidemic crisis in 2021. We...
3.
Pornprom T, Phusi N, Thongdee P, Pakamwong B, Sangswan J, Kamsri P, et al.
Talanta . 2023 Sep; 267:125210. PMID: 37717539
Tuberculosis (TB) currently remains a major life-threatening disease as it can be fatal if not treated properly or in a timely manner. Herein, we first describe a disposable and cost-effective...
4.
Chevaisrakul P, Lumjiaktase P, Kietdumrongwong P, Chuatrisorn I, Chatsangjaroen P, Phanuphak N
Sci Rep . 2023 Jan; 13(1):763. PMID: 36641523
The death rate from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in 2022 was lower than the death rate in 2021, when the infection rate increased. Hybrid immunity provided...
5.
Srichomchey P, Sukprasert S, Khulasittijinda N, Voravud N, Sahakitrungruang C, Lumjiaktase P
In Vivo . 2023 Jan; 37(1):286-293. PMID: 36593062
Background/aim: Vitamin D (VD) affects the regulation of the immune system, including the differentiation and function of regulatory T-cells (Tregs). Tregs play an important role in maintaining immune homeostasis in...
6.
Rattanamanee T, Lumjiaktase P, Kemawichanura N, Kiewnga P, Jotikasthira W, Manuyakorn W
Asia Pac Allergy . 2022 Feb; 12(1):e4. PMID: 35174055
Background: House dust mites (HDM) are the major causative allergen for allergic rhinitis. The sole disease-modifying therapy for allergic rhinitis is allergen immunotherapy (AIT). Rush immunotherapy is the accelerated build-up...
7.
Khositnithikul R, Laisuan W, Setthaudom C, Sriwanichrak K, Kunakorn M, Srikhirin T, et al.
Lab Med . 2021 Aug; 53(1):12-17. PMID: 34463313
Objective: Patients who develop interferon-gamma autoantibodies (IFN-ɤ autoAbs) in adult-onset immunodeficiency (AOID) syndrome are more likely to develop opportunistic and recurrent intracellular infections. The assay to detect IFN-ɤ autoAbs is...
8.
Kanjana K, Chevaisrakul P, Matangkasombut P, Paisooksantivatana K, Lumjiaktase P
Sci Rep . 2020 Nov; 10(1):19789. PMID: 33188235
Immune regulation status may indicate immunological remission in rheumatoid arthritis (RA). This cross-sectional study aimed to determine the Regulatory T cell (Treg) properties, together with 14 plasma cytokines levels between...
9.
Rattanamanee T, Lumjiaktase P, Kemawichanura N, Kiewgnam P, Jotikasthira W, Manuyakorn W
Asian Pac J Allergy Immunol . 2020 Oct; 41(3):193-198. PMID: 33068370
Background: Rush venom immunotherapy (VIT) is the recommended treatment for patients with Hymenoptera anaphylaxis. Specific data regarding regulatory T cell and cytokine changes in children receiving rush VIT are sparse....
10.
Kanjana K, Chevaisrakul P, Matangkasombut P, Paisooksantivatana K, Lumjiaktase P
Front Med (Lausanne) . 2020 Mar; 7:25. PMID: 32118010
When the dose of conventional disease-modifying anti-rheumatic drugs (cDMARDs) is tapered in rheumatoid arthritis (RA) patients who achieve sustained remission, biomarkers for predicting disease relapse may be needed. A prospective,...